Vv. Ogryzko et al., WAF1 RETARDS S-PHASE PROGRESSION PRIMARILY BY INHIBITION OF CYCLIN-DEPENDENT KINASES, Molecular and cellular biology, 17(8), 1997, pp. 4877-4882
The p(2WAF1/CIP1/sdi1) gene product (WAF1) inhibits DNA replication in
vitro (J. Chen, P. Jackson, M. Kirschner, and A. Dutta, Nature 374:38
6-388, 1995; S. Waga, G. Hannon, D. Beach, and B. Stillman, Nature 369
:574-578, 1994), but in vivo studies on the antiproliferative activity
of WAF1 have not resolved G(1)-phase arrest from potential inhibition
of S-phase progression. Here, we demonstrate that elevated WAF1 expre
ssion can retard replicative DNA synthesis in vivo. The WAF1-mediated
inhibitory effect could be antagonized by cyclin A, cyclin E, or the s
imian virus 40 small-t antigen with no decrease in the levels of WAF1
protein in transfected cells, Proliferating-cell nuclear antigen (PCNA
) overexpression was neither necessary nor sufficient to antagonize WA
F1 action, Expression of the N-terminal domain of WAF1, responsible fo
r cyclin-dependent kinase (CDK) interaction, had the same effect as fu
ll-length WAF1, while the PCNA binding C terminus exhibited modest act
ivity. We conclude that S-phase progression in mammalian cells is depe
ndent on continuing cyclin and CDK activity and that WAF1 affects S ph
ase primarily through cyclin- and CDK-dependent pathways.